Levy Henry 4

What Happened

• Levy Henry, President, Life Sciences & Healthcare (LS&H) at Clarivate, was issued 36,847 shares on 2026-02-18 in settlement of performance share units (award code A). The shares show an acquisition price of $0.00 (awarded, no purchase price).
• To cover the tax liability from the vesting, Clarivate withheld 18,115 shares (disposition code F) at $1.78 per share, resulting in $32,245 withheld. Net shares delivered to Henry after withholding: 18,732.

Key Details

• Transaction date: 2026-02-18; Form 4 filed 2026-02-20 (timely).
• Award: 36,847 shares issued in settlement of 2023 performance share units that vested upon achievement and certification of the performance condition (footnote F1).
• Tax withholding: 18,115 shares withheld by the issuer to satisfy tax obligations at $1.78/share, totaling $32,245 (footnote F2).
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Transaction codes: A = Award/Grant; F = Tax withholding (issuer share-withholding rather than open-market sale).

Context

• This was a settlement of performance-based awards, not an open-market purchase or voluntary sale. The withholding of shares to cover taxes is a common administrative step (cashless tax withholding) and does not necessarily indicate a change in the insider’s market view.
• The award was granted previously (2023) and vested after the company certified performance conditions; the $0.00 acquisition price reflects that these were issued as compensation rather than bought.